Frontier Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-508,651
Closed -$3.01M 298
2025
Q2
$3.01M Sell
508,651
-1,485
-0.3% -$8.54K 0.03% 280
2025
Q1
$3.26M Sell
510,136
-15,602
-3% -$150K 0.04% 268
2024
Q4
$6.25M Sell
525,738
-182,976
-26% -$3.12M 0.06% 246
2024
Q3
$19.6M Sell
708,714
-1,036,647
-59% -$25.9M 0.18% 170
2024
Q2
$41.6M Sell
1,745,361
-327,428
-16% -$7.69M 0.41% 94
2024
Q1
$36.5M Buy
2,072,789
+621,032
+43% +$9.15M 0.34% 113
2023
Q4
$22.9M Buy
1,451,757
+488,170
+51% +$5.04M 0.23% 152
2023
Q3
$8.29M Buy
+963,587
New +$6.85M 0.09% 202

Other funds holding ASPN

Frontier Capital Management's ASPN Position: Q3 2025 in Review

Frontier Capital Management sold out of Aspen Aerogels (ASPN) in Q3 2025, closing a stake of 508,651 shares — an estimated $3.01M sold.

Frontier Capital Management first reported a position in ASPN in Q3 2023 and held it in 8 quarters. The position peaked at $41.6M in Q2 2024. 204 funds tracked by Wall St. Rank hold ASPN as of Q3 2025.

  • Frontier Capital Management reported no remaining Aspen Aerogels position as of Q3 2025 after selling out during the quarter.
  • Frontier Capital Management sold 508,651 Aspen Aerogels shares in Q3 2025, an estimated $3.01M.
  • Frontier Capital Management first reported a position in Aspen Aerogels in Q3 2023 and held it in 8 quarters.
  • Frontier Capital Management's Aspen Aerogels position peaked at $41.6M in Q2 2024.
  • 204 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2025.

Based on Frontier Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.